Biocon shares tank 6% after reporting net loss of Rs 16 cr in Q2FY25

Quick Summary:

Shares of pharmaceutical company Biocon tanked 5.96 per cent at Rs 301.

Biocon Group CEO Peter Bains attributed the loss to the increased tax burden related to the geographical distribution of profits and minority interest.

She expressed optimism about all three business segments, anticipating better performance in the second half of the year due to product approvals and emerging market opportunities.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaOman

Topics: Biocon shares Biocon share price Biocon Sensex Buzzing stocks Biocon share price Biocon news Biocon share price today Stock market

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-31 @ 11:45:54 (10 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 647 words

Reading Time: 4 minutes read

Sentences: 29 lines

Sentence Length: 23 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23345877

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 220 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions